Deitelzweig, S
39  Ergebnisse:
Personensuche X
?
1

Clinical impact of switching or continuation of apixaban or..:

Deitelzweig, S ; Kang, A ; Jiang, J...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
 
?
4

Effectiveness and safety of non-vitamin K antagonist oral a..:

Lip, G.Y.H ; Keshishian, A ; Kang, A...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
5

Effectiveness and safety of non-vitamin K antagonist oral a..:

Lip, G.Y.H ; Keshishian, A ; Kang, A...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
6

Time at home among nonvalvular atrial fibrillation patients..:

Deitelzweig, S ; Keshishian, A ; Kang, A...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
7

Time at home among nonvalvular atrial fibrillation patients..:

Deitelzweig, S ; Keshishian, A ; Kang, A...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
 
?
9

Comparative effectiveness and safety of non-vitamin K antag..:

Galinier, M. ; Deitelzweig, S. ; Keshishian, A....
Archives of Cardiovascular Diseases Supplements.  11 (2019)  1 - p. 150 , 2019
 
?
11

Comparative effectiveness and safety between non-VKA oral a..:

Picard, F. ; Lip, G.Y.H. ; Keshishian, A....
Archives of Cardiovascular Diseases Supplements.  11 (2019)  1 - p. 151 , 2019
 
?
12

P4768Comparative effectiveness and safety between non-VKA o..:

Deitelzweig, S ; Keshishian, A ; Kang, A...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
13

P4794Comparative effectiveness and safety of non-VKA oral a..:

Deitelzweig, S ; Keshishian, A ; Kang, A...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
14

P2903Comparative effectiveness and safety between non-VKA o..:

Lip, G Y H ; Keshishian, A ; Li, X...
European Heart Journal.  39 (2018)  suppl_1 - p. , 2018
 
?
 
1-15